Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 21, 2018
Pharmacy Choice - News - Front Page Healthcare News - October 21, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/20/18 - $4.95 Bn Microbiology Testing/Clinical Microbiology Market - Global Forecast to 2023
The growth of the reagents segment can be attributed to the high prevalence of infectious diseases across major markets, growing trend of reagent rental agreements along with instrument sales, and the increasing number of life science researches in the field of pathogen-specific reagents. North America is expected to hold the largest share of the g
9/20/18 - 19th Annual Conference on Alzheimer's Drug Discovery Highlights Multiple Approaches to Prevent and Treat Alzheimer's Disease
Nearly 200 academic and industry researchers gathered this week to share updates on preclinical and clinical-stage Alzheimer's disease research at the 19th International Conference on Alzheimer's Drug Discovery. The two-day conference, organized by the Alzheimer's Drug Discovery Foundation, focused on gene therapy and alternative modalities for..
9/20/18 - 5 Key Research Findings on Dual Chamber Prefilled Syringes Market from Fact.MR's Report for Forecast [ClickPress (UK)]
According to Fact.MR s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period. Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026- end. Dual Chamber Prefilled Syringes Efficient So
9/20/18 - 7 Best Biotech Stocks for Investors Who Hate Risk
Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the expiration of a crucial patent leading to massive stock plunges have circulated for years now, souring would-be buyers on the entire industry.
9/20/18 - 9 Glucose Monitoring Device Stocks
Demand for glucose monitoring devices with the most advanced technology is growing as the number of diabetic patients increases.. The rate of diabetes has doubled from 4.7 percent in 1980 to 8.5 percent in 2014, according to the World Health Organization. This increase amounts to 422 million adults diagnosed with the disease in 2015, and diabetes i
9/20/18 - ACCC won't oppose Arrow and Apotex merger
Combined, they will supply around half the market for generic prescription pharmaceuticals to pharmacies in Australia. However, we found that a combined Arrow-Apotex would continue to face strong competition from Mylan and Sandoz, and to a lesser extent from short range suppliers like Generic Health and Pharmacor. These suppliers are backed by stro
9/20/18 - Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare Disease
Actinium Pharmaceuticals, Inc. today announced that the Company will participate in the Oppenheimer& Co. Fall Summit Focused on Specialty Pharma and Rare Disease, to be held September 26-27, 2018 in New York City. To schedule a meeting with Actinium, please contact Steve O'Loughlin, Principal Financial Officer via email soloughlin@actiniumpharma.
9/20/18 - ADVENT ACCESS COMPLETES CE MARK SUBMISSION FOR av-GuardianTM
Singapore, 20 September 2018 Advent Access, one of Singapore s most innovative medtech companies, today announced that it has completed the regulatory submission and key audits for the CE Mark in the European Union for its award-winning av-Guardian TM technology. The submission represents a significant step towards commercialisation of av-Gua
9/20/18 - Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
Amicus Therapeutics today announced the signing of a definitive agreement in which Amicus Therapeutics will receive worldwide development and commercial rights for ten gene therapy programs developed at The Center for Gene Therapy at The Research Institute at Nationwide Children s Hospital and The Ohio State University. The in-licensing and
9/20/18 - AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections [Syrian Arab News Agency]
AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01,...
9/20/18 - An Essential Overview of the Medical Device Industry (London, United Kingdom - May 21, 2019)
The "An Essential Overview of the Medical Device Industry" conference has been added to ResearchAndMarkets.com' s offering. The Pharmaceutical Industry is increasingly developing Device combination products and looking to use novel methods of drug delivery.to enhance the performance of medicine and as a part of life cycle management.
9/20/18 - An Essential Overview of the Medical Device Industry (London, United Kingdom - May 21, 2019) - ResearchAndMarkets.com
The "An Essential Overview of the Medical Device Industry" conference has been added to ResearchAndMarkets.com' s offering. The Pharmaceutical Industry is increasingly developing Device combination products and looking to use novel methods of drug delivery to enhance the performance of medicine and as a part of life cycle management.
9/20/18 - An Essential Overview of the Medical Device Industry (London, United Kingdom - November 8, 2018)
The "An Essential Overview of the Medical Device Industry" conference has been added to ResearchAndMarkets.com' s offering. The Pharmaceutical Industry is increasingly developing Device combination products and looking to use novel methods of drug delivery.to enhance the performance of medicine and as a part of life cycle management.
9/20/18 - An Essential Overview of the Medical Device Industry (London, United Kingdom - November 8, 2018) - ResearchAndMarkets.com
The "An Essential Overview of the Medical Device Industry" conference has been added to ResearchAndMarkets.com' s offering. The Pharmaceutical Industry is increasingly developing Device combination products and looking to use novel methods of drug delivery.to enhance the performance of medicine and as a part of life cycle management.
9/20/18 - Antisense & RNAi Therapeutics Market Driven By Rising Use Of Antisense Technology For Disease Management Till 2025: Grand View Research, Inc.
The global antisense and RNAi therapeutics market size is expected to reach USD 1.81 billion by 2025, according to report by Grand View Research, Inc. Rising instances of external funding to conduct clinical studies pertaining to introduction of novel drug moieties plays a vital role in the process of new product development. According to a report.
9/20/18 - APEIRON Announces Collaboration with Lead Discovery Center GmbH [All Iraq News Agency (AIN)]
-APEIRON Biologics AG, an Austrian company focused on cancer immunotherapy, today announced a collaboration agreement with the Lead Discovery Center GmbH, a translational research organization established in 2008 by Max Planck Innovation, to develop novel immune checkpoint modulators. Peter Llewellyn-Davies, Chief Executive Officer of APEIRON...
9/20/18 - Apple Watch received FDA clearance just one day before the launch; cardiologist questions ECG accuracy [T-break Tech (Middle East)]
Apple made a big deal of the ECG functionality of the Apple Watch Series 4, and emphasized that the feature had received FDA clearance. Some on the Apple Watch team may have felt their hearts pounding in the days leading up to the big Apple Watch 4 unveiling in Cupertino last week. I overheard an Apple employee talking about the near-miss in exaspe
9/20/18 - Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets,...
9/20/18 - ARALEZ PHARMACEUTICALS INC. (NASDAQ:ARLZ) Files An 8-K Entry into a Material Definitive Agreement
ARALEZ PHARMACEUTICALS INC. (NASDAQ:ARLZ) Files An 8-K Entry into a Material Definitive AgreementItem 1.01- Entry Into a Material Definitive Agreement On September18, 2018, Aralez Pharmaceuticals Inc. (the Company) and certain of its subsidiaries entered into two purchase agreements with Nuvo Pharmaceuticals Inc. (Nuvo) and its affiliat
9/20/18 - Arcus Biosciences Announces Participation at Leerink Partners Roundtable Series: Rare Disease & Oncology
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced Terry Rosen, Ph.D., Chief Executive Officer, and Jennifer Jarrett, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Leerink Partners Roundtable Series: Rare Disease
9/20/18 - Arthroscopy Instrument Market: Global Industry Analysis, Trends, Market Size and Forecasts to 2024
In terms of geographic, North America has dominated the Arthroscopy Instrument Market followed by Europe and Asia Pacific. In North America factors such as growing frequencies of joint-related diseases, high rate of sports-related surgery, and development of advanced surgical instruments are driving the growth of this market in the North America re
9/20/18 - Arthroscopy Instrument Market: Global Industry Analysis, Trends, Market Size and Forecasts to 2024 - ResearchAndMarkets.com
In terms of geographic, North America has dominated the Arthroscopy Instrument Market followed by Europe and Asia Pacific. In North America factors such as growing frequencies of joint-related diseases, high rate of sports-related surgery, and development of advanced surgical instruments are driving the growth of this market in the North America re
9/20/18 - AstraZenecas Asthma Drug Looks Good in Multiple Late-Stage Trials [Sudan Tribune]
AstraZeneca released positive results from the BORA Phase III extension clinical trial of Fasenra as an add-on maintenance therapy in patients with severe eosinophilic asthma that had already completed either the SIROCCO or CALIMA Phase III trials. The BORA trial had patients receive Fasenra for another 56 weeks to evaluate long-term safety and...
9/20/18 - Automated Microscopy Market Projected to Be Resilient During 2024: XploreMR delivers incisive insights into emerging regions in its latest report titled, Automated Microscopy Market (Product - Optical Microscope (Inverted Microscope, Stereomicrosc
Valley Cottage, NY 09/19/2018 Global Automated Microscopy Market: Overview. Automated Microscopy devices, electromechanically determines and adjusts the correct wavelength, required focus, light shutter control, stage control, and illumination source for imaging live-cell. Automated microscopy accessories and components enable the investigato
9/20/18 - Ayurvedic Medicine Market 2018 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2023
WiseGuyReports.com adds "Ayurvedic Medicine Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023". The study objectives are to present the Ayurvedic Medicine development in United States, Europe and China. In countries beyond India, Ayurveda therapies and practices have been integrated in general wellnes
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415